RepliCel Life Sciences News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

19.06.18	IIROC Trading Resumption - BTR; MTO (PR Newswire)
18.05.18	Le gouvernement du Québec récompense des Québécoises et des Québécois ainsi que des organisations qui contribuent au rayonnement du français (PR Newswire)
02.05.18	RepliCel Life Sciences Now Finalizing its Strategic Investment Partnership with China-based YOFOTO (PR Newswire)
02.05.18	RepliCel Life Sciences Now Finalizing its Strategic Investment Partnership with China-based YOFOTO (PR Newswire)
25.01.18	RepliCel CEO Provides 2018 Shareholder Update (PR Newswire)
25.01.18	RepliCel CEO Provides 2018 Shareholder Update (PR Newswire)
16.01.18	RepliCel Life Sciences Lands Commitment for Key Investment Partnership (PR Newswire)
16.01.18	RepliCel Life Sciences Lands Commitment for Key Investment Partnership (PR Newswire)
05.01.18	Louis Vachon prendra la parole à la Conférence des chefs de direction de banques canadiennes de RBC Marchés des Capitaux (PR Newswire)
07.11.17	Logistec annonce ses résultats au troisième trimestre de 2017 (PR Newswire)
31.10.17	Seaspan Appoints Bing Chen as Chief Executive Officer (PR Newswire)
30.10.17	BMO Financial Group has Commitments of over $38 Million in Donations and Pledges to Community Programs in Quebec to Mark Bicentennial Year (PR Newswire)
10.10.17	Avis aux médias - Acquisition de 726 logements par l'OBNL Gérer son quartier pour le maintien de logements abordables (PR Newswire)
03.10.17	IIROC Trade Resumption - CME (PR Newswire)
03.10.17	/R E P R I S E -- Avis aux médias - Élection municipale du 5 novembre 2017 - Annonce d'une importante infrastructure sportive dans l'ouest de la ville de Montréal/ (PR Newswire)
02.10.17	The Ivory Madonnas - When Besner honours his Elite - The event of the season at Gallery MX From November 8th to November 19th, 2017 (PR Newswire)
26.09.17	Dr. Mohamed Mostafa from Microdrones presents at Intergeo 2017 in Berlin (PR Newswire)
25.09.17	RefPlus embauche Hamed Khakpour, Jr. Ing. (PR Newswire)
23.09.17	RepliCel Retains Hybrid Financial for Investor Relations (PR Newswire)
23.09.17	RepliCel Retains Hybrid Financial for Investor Relations (PR Newswire)
22.09.17	/R E P R I S E -- Invitation aux médias - Annonce concernant une entente de développement culturel/ (PR Newswire)
13.09.17	RepliCel's Partnership Initiatives Mature into Licensing Negotiations (PR Newswire)
07.09.17	RepliCel Showcases First Fully-Functional Prototypes of its Next-Generation Dermal Injector (PR Newswire)
30.08.17	Planon Achieves "Leader" Status in the Green Quadrant® Integrated Workplace Management Systems (PR Newswire)
10.08.17	Prominent Skin Aging Researcher Provides Insights into RepliCel's Clinical Data (PR Newswire)
13.06.17	RepliCel Collaborates with University of British Columbia to Build World-Class Hair Follicle Cell Data Map (PR Newswire)
25.05.17	RepliCel CEO Provides Company Outlook (PR Newswire)
25.04.17	United States Patent Issued to RepliCel for its Novel Dermal Injection Technologies (PR Newswire)
04.04.17	Clinical Trial Advancements With Positive Data for Phase 1 and 2 Results Fueling Steady Growth in Biomedical Industry (PR Newswire)
04.04.17	Clinical Trial Advancements With Positive Data for Phase 1 and 2 Results Fueling Steady Growth in Biomedical Industry (PR Newswire)
04.04.17	Positive Results from RepliCel's RCS-01 Phase I Skin Trial are the Company's Most Compelling to Date (PR Newswire)
28.03.17	The Growth of the Regenerative Medicines Market (PR Newswire)
28.03.17	Tendon Repair and Regenerative Biomedicine Market Fastest Growing Segment in Tissue Engineering Segment (PR Newswire)
28.03.17	Tendon Repair and Regenerative Biomedicine Market Fastest Growing Segment in Tissue Engineering Segment (PR Newswire)
28.03.17	RepliCel's Successful RCT-01 Tendon Repair Clinical Trial Shows Signs of Healing Chronic Tendon Problems (PR Newswire)
14.03.17	Technological Advances in the Regenerative Medicine Markets (PR Newswire)
14.03.17	RepliCel's Phase 1 Clinical Trial for Hair Loss Succeeds in Meeting Primary Endpoints (PR Newswire)
07.03.17	RepliCel Pursues Non-Diluting Grant Funding to Accelerate Value Creation and Commercialization (PR Newswire)
28.02.17	RepliCel Signs Two Key Service Partnerships for Final Prototype Manufacturing and Testing of its Dermal Injector (PR Newswire)
09.02.17	RepliCel Announces European Patents for its Innovative Dermal Injector Technologies (PR Newswire)
03.02.17	RepliCel Appoints Corporate Executive, Hugh Rogers to its Board of Directors (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Holcim	91.22	1.56 %	K V
Sonova Hldg	319.70	1.56 %	K V
Lonza Grp	591.00	1.34 %	K V
Sika	231.50	1.27 %	K V
CieFinRichemont	171.70	0.94 %	K V
Swiss Re	138.05	-0.40 %	K V
Zurich Insur Gr	537.20	-0.52 %	K V
Kuehne+Nagel Int	204.60	-0.97 %	K V
Part Grp Hldg	1’389.50	-1.03 %	K V
Givaudan	3’818.00	-3.12 %	K V

Nachrichten zu RepliCel Life Sciences Inc.

Aktien Top/Flop

Meistgelesene Nachrichten